NBN, BARD1, and BRIP1 are associated with BRCA1, and MRE11 and RAD52 are associated with BRCA2; their expression was upregulated only in HRD tumors24–27. The gene discussed is BARD1; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.